BMPR1B and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, the BMP pathway has been revealed to be impaired in different disease stages, with almost half of newly diagnosed patients displaying high levels of BMPR1B/ALK6 [15–17, 43].